Feedback / Questions
64/67Cu SAR-bisPSMA theranostic - Clarity Pharma
https://www.prnewswire.com/news-releases/secure-trial-advances-no-dose-limiting-toxicities-and-strong-preliminary-efficacy-data-in-first-multi-dose-cohort-302245899.html
Sep 12, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next